ENSG00000073578 |
|
melanoma |
sequence_alteration |
6.207% (9/145) |
2 entries |
ENSG00000073578 |
|
hemangioblastoma |
sequence_alteration |
17.14% (6/35) |
1 entry |
ENSG00000073578 |
|
melanoma |
missense_variant |
6.207% (9/145) |
2 entries |
ENSG00000073578 |
|
colorectal adenocarcinoma |
missense_variant |
2.575% (31/1204) |
2 entries |
ENSG00000073578 |
|
melanoma |
frameshift_variant |
6.207% (9/145) |
1 entry |
ENSG00000073578 |
|
colorectal adenocarcinoma |
sequence_alteration |
2.575% (31/1204) |
1 entry |
ENSG00000073578 |
|
breast ductal adenocarcinoma |
missense_variant |
1.564% (25/1598) |
1 entry |
ENSG00000073578 |
|
brain glioblastoma |
sequence_alteration |
0.2473% (3/1213) |
1 entry |
ENSG00000073578 |
|
bladder transitional cell carcinoma |
missense_variant |
0.8715% (4/459) |
2 entries |
ENSG00000073578 |
|
small cell lung carcinoma |
missense_variant |
0.905% (4/442) |
3 entries |
ENSG00000073578 |
|
skin melanoma |
sequence_alteration |
0.9483% (11/1160) |
3 entries |
ENSG00000073578 |
|
lung adenocarcinoma |
sequence_alteration |
0.7486% (19/2538) |
3 entries |
ENSG00000073578 |
|
prostate carcinoma |
sequence_alteration |
0.4695% (2/426) |
1 entry |
ENSG00000073578 |
|
Endometrial Endometrioid Adenocarcinoma |
missense_variant |
2.465% (16/649) |
1 entry |
ENSG00000073578 |
|
oral squamous cell carcinoma |
missense_variant |
0.7634% (2/262) |
2 entries |
ENSG00000073578 |
|
rectal adenocarcinoma |
sequence_alteration |
1.832% (10/546) |
2 entries |
ENSG00000073578 |
|
prostate adenocarcinoma |
missense_variant |
0.9772% (21/2149) |
2 entries |
ENSG00000073578 |
|
esophageal adenocarcinoma |
missense_variant |
2.559% (14/547) |
1 entry |
ENSG00000073578 |
|
gastric adenocarcinoma |
missense_variant |
0.9512% (8/841) |
1 entry |
ENSG00000073578 |
|
bladder transitional cell carcinoma |
sequence_alteration |
0.8715% (4/459) |
2 entries |
ENSG00000073578 |
|
nasopharyngeal squamous cell carcinoma |
sequence_alteration |
1.111% (2/180) |
1 entry |
ENSG00000073578 |
|
clear cell renal carcinoma |
missense_variant |
0.2003% (3/1498) |
1 entry |
ENSG00000073578 |
|
cecum adenocarcinoma |
missense_variant |
1.859% (5/269) |
3 entries |
ENSG00000073578 |
|
breast ductal adenocarcinoma |
sequence_alteration |
1.564% (25/1598) |
1 entry |
ENSG00000073578 |
|
skin melanoma |
missense_variant |
0.9483% (11/1160) |
3 entries |
ENSG00000073578 |
|
pancreatic ductal adenocarcinoma |
missense_variant |
1.723% (29/1683) |
1 entry |
ENSG00000073578 |
|
squamous cell lung carcinoma |
sequence_alteration |
0.7511% (7/932) |
1 entry |
ENSG00000073578 |
|
colon adenocarcinoma |
missense_variant |
1.479% (19/1285) |
3 entries |
ENSG00000073578 |
|
clear cell renal carcinoma |
sequence_alteration |
0.2003% (3/1498) |
1 entry |
ENSG00000073578 |
|
hepatocellular carcinoma |
missense_variant |
0.9146% (9/984) |
1 entry |
ENSG00000073578 |
|
anaplastic oligodendroglioma |
missense_variant |
3.529% (3/85) |
1 entry |
ENSG00000073578 |
|
squamous cell lung carcinoma |
missense_variant |
0.7511% (7/932) |
2 entries |
ENSG00000073578 |
|
diffuse large B-cell lymphoma |
missense_variant |
0.5376% (2/372) |
2 entries |
ENSG00000073578 |
|
head and neck squamous cell carcinoma |
sequence_alteration |
1.431% (9/629) |
1 entry |
ENSG00000073578 |
|
lung adenocarcinoma |
missense_variant |
0.7486% (19/2538) |
3 entries |
ENSG00000073578 |
|
cecum adenocarcinoma |
sequence_alteration |
1.859% (5/269) |
1 entry |
ENSG00000073578 |
|
colon adenocarcinoma |
sequence_alteration |
1.479% (19/1285) |
3 entries |
ENSG00000073578 |
|
prostate adenocarcinoma |
sequence_alteration |
0.9772% (21/2149) |
2 entries |
ENSG00000073578 |
|
gastric adenocarcinoma |
sequence_alteration |
0.9512% (8/841) |
2 entries |
ENSG00000073578 |
|
Endometrial Endometrioid Adenocarcinoma |
stop_gained |
2.465% (16/649) |
1 entry |
ENSG00000073578 |
|
rectal adenocarcinoma |
missense_variant |
1.832% (10/546) |
2 entries |
ENSG00000073578 |
|
esophageal adenocarcinoma |
sequence_alteration |
2.559% (14/547) |
1 entry |
ENSG00000073578 |
|
anaplastic oligodendroglioma |
sequence_alteration |
3.529% (3/85) |
1 entry |
ENSG00000073578 |
|
non-small cell lung carcinoma |
missense_variant |
1.064% (2/188) |
1 entry |
ENSG00000073578 |
|
Parathyroid Gland Carcinoma |
frameshift_variant |
2.857% (1/35) |
1 entry |
ENSG00000073578 |
|
Spinal Cord Astrocytoma |
frameshift_variant |
25.0% (1/4) |
1 entry |
ENSG00000073578 |
|
Gastrointestinal stromal tumor |
stop_gained |
1.351% (2/148) |
1 entry |
ENSG00000073578 |
|
Gastrointestinal stromal tumor |
missense_variant |
1.351% (2/148) |
1 entry |
ENSG00000073578 |
|
leiomyosarcoma |
missense_variant |
1.0% (1/100) |
1 entry |
ENSG00000073578 |
|
Spinal Cord Astrocytoma |
sequence_alteration |
25.0% (1/4) |
1 entry |
ENSG00000073578 |
|
small cell lung carcinoma |
sequence_alteration |
0.905% (4/442) |
1 entry |
ENSG00000073578 |
|
Gallbladder Adenocarcinoma |
sequence_alteration |
0.7194% (1/139) |
1 entry |
ENSG00000073578 |
|
urothelial carcinoma |
sequence_alteration |
1.163% (1/86) |
1 entry |
ENSG00000073578 |
|
urothelial carcinoma |
missense_variant |
1.163% (1/86) |
1 entry |
ENSG00000073578 |
|
non-small cell lung carcinoma |
stop_lost |
1.064% (2/188) |
1 entry |
ENSG00000073578 |
|
Paraganglioma |
missense_variant |
25.0% (2/8) |
1 entry |
ENSG00000073578 |
|
ovarian serous adenocarcinoma |
frameshift_variant |
0.3601% (3/833) |
1 entry |
ENSG00000073578 |
|
PEComa |
sequence_alteration |
6.667% (1/15) |
1 entry |
ENSG00000073578 |
|
gastric intestinal type adenocarcinoma |
frameshift_variant |
2.353% (2/85) |
1 entry |
ENSG00000073578 |
|
dedifferentiated chondrosarcoma |
sequence_alteration |
6.25% (1/16) |
1 entry |
ENSG00000073578 |
|
metaplastic breast carcinoma |
sequence_alteration |
1.667% (1/60) |
1 entry |
ENSG00000073578 |
|
basal cell carcinoma |
missense_variant |
1.471% (1/68) |
1 entry |
ENSG00000073578 |
|
angiosarcoma |
sequence_alteration |
2.128% (1/47) |
1 entry |
ENSG00000073578 |
|
PEComa |
missense_variant |
6.667% (1/15) |
1 entry |
ENSG00000073578 |
|
esophageal squamous cell carcinoma |
frameshift_variant |
0.2924% (2/684) |
1 entry |
ENSG00000073578 |
|
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
missense_variant |
0.3788% (1/264) |
1 entry |
ENSG00000073578 |
|
brain glioblastoma |
missense_variant |
0.2473% (3/1213) |
1 entry |
ENSG00000073578 |
|
head and neck squamous cell carcinoma |
missense_variant |
1.431% (9/629) |
1 entry |
ENSG00000073578 |
|
Ocular Sebaceous Carcinoma |
missense_variant |
4.348% (1/23) |
1 entry |
ENSG00000073578 |
|
Gallbladder Adenocarcinoma |
missense_variant |
0.7194% (1/139) |
1 entry |
ENSG00000073578 |
|
Mantle cell lymphoma |
missense_variant |
1.887% (1/53) |
1 entry |
ENSG00000073578 |
|
Major Salivary Gland Mucoepidermoid Carcinoma |
missense_variant |
50.0% (1/2) |
1 entry |
ENSG00000073578 |
|
Paraganglioma |
sequence_alteration |
25.0% (2/8) |
1 entry |
ENSG00000073578 |
|
lung carcinoid tumor |
missense_variant |
3.704% (1/27) |
1 entry |
ENSG00000073578 |
|
adenosquamous lung carcinoma |
missense_variant |
4.545% (1/22) |
1 entry |
ENSG00000073578 |
|
gastric intestinal type adenocarcinoma |
missense_variant |
2.353% (2/85) |
1 entry |
ENSG00000073578 |
|
Major Salivary Gland Mucoepidermoid Carcinoma |
sequence_alteration |
50.0% (1/2) |
1 entry |
ENSG00000073578 |
|
nasopharyngeal squamous cell carcinoma |
missense_variant |
1.111% (2/180) |
1 entry |
ENSG00000073578 |
|
osteosarcoma |
sequence_alteration |
0.6579% (1/152) |
1 entry |
ENSG00000073578 |
|
dedifferentiated chondrosarcoma |
missense_variant |
6.25% (1/16) |
1 entry |
ENSG00000073578 |
|
ovarian serous adenocarcinoma |
missense_variant |
0.3601% (3/833) |
1 entry |
ENSG00000073578 |
|
non-small cell lung carcinoma |
sequence_alteration |
1.064% (2/188) |
1 entry |
ENSG00000073578 |
|
chronic myelomonocytic leukemia |
missense_variant |
1.053% (1/95) |
1 entry |
ENSG00000073578 |
|
bile duct adenocarcinoma |
missense_variant |
0.2571% (1/389) |
1 entry |
ENSG00000073578 |
|
laryngeal squamous cell carcinoma |
missense_variant |
2.439% (1/41) |
1 entry |
ENSG00000073578 |
|
ovarian serous adenocarcinoma |
sequence_alteration |
0.3601% (3/833) |
1 entry |
ENSG00000073578 |
|
bladder transitional cell carcinoma |
frameshift_variant |
0.8715% (4/459) |
1 entry |